BiotechTube

MAT2203 + Amphotericin B

Phase 3UNKNOWN
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Cryptococcal Meningitis

Conditions

Cryptococcal Meningitis

Trial Timeline

Jan 1, 2023 → Jan 1, 2025

NCT ID
NCT05541107

About MAT2203 + Amphotericin B

MAT2203 + Amphotericin B is a phase 3 stage product being developed by Matinas Biopharma for Cryptococcal Meningitis. The current trial status is unknown. This product is registered under clinical trial identifier NCT05541107. Target conditions include Cryptococcal Meningitis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT05541107Phase 3UNKNOWN
NCT04031833Phase 1/2Completed

Competing Products

18 competing products in Cryptococcal Meningitis

See all competitors
ProductCompanyStageHype Score
Efungumab (Mycograb) + placebo + Amphotericin B + 5 flucytosineNovartisPhase 2
52
Mycograb + placeboNovartisPhase 2
52
Single dose liposomal Amphotericin and Fluconazole + FluconazoleGilead SciencesPhase 2/3
64
FluconazolePfizerPre-clinical
22
FluconazolePfizerPre-clinical
22
Fluconazole + Amphotericin BPfizerPre-clinical
22
Flucytosine + FluconazolePfizerPre-clinical
22
Fluconazole + Amphotericin BPfizerPre-clinical
22
Flucytosine + Fluconazole + Amphotericin BPfizerPre-clinical
22
FluconazolePfizerPre-clinical
22
FluconazolePfizerPre-clinical
22
Fluconazole + Amphotericin BPfizerPhase 3
76
Flucytosine + Fluconazole + Amphotericin BPfizerPre-clinical
22
FluconazolePfizerPre-clinical
22
Lobradimil + Amphotericin BAlkermesPhase 1
30
Flucytosine and fluconazole + FluconazoleBausch HealthPhase 2
47
MAT2203 + Amphotericin BMatinas BiopharmaPhase 1/2
33
Encochleated Amphotericin BMatinas BiopharmaPhase 1/2
33

Other Products from Matinas Biopharma

Placebo + MAT9001 (omega-3 pentaenoic acid)Phase 3
69
Oral Encochleated Amphotericin B (CAMB)Phase 2
44
Amphotericin BPhase 2
44
Omega 3 pentaenoic acid + icosapent ethylPhase 2
44
Oral Encochleated Amphotericin B (CAMB) + Oral Encochleated Amphotericin B (CAMB)Phase 2
44